LRRK2 and Parkinson disease: MSEA also showed that metabolic pathways, namely, propionate metabolism, inositol metabolism, and inositol phosphate metabolism, were significantly disturbed when sPD was compared with LRRK2 PD CSF (p < 0.05; q < 0.1; Supplementary Table S6).